Product Profile
no_image no_image no_image no_image no_image no_image no_image no_image no_image no_image
PRODUCTS DISEASE PHARMACOVIGILANCE MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
ROCULAX
ROCULAX

ROCULAX

BRANDED
Rocuronium is a nondepolarizing neuromuscular agent with rapid to intermediate onset depending on dose, and intermediate duration.
Available at :
Share this article
Related Articles
5248d331a55c861de40d8d12f1467605.jpg
Vitamins K2 and D3 Help Treat Long COVID, Reduce Fungal Translocation, and Suppress Inflammation
by dr. Karen Denisa | 08 Oct 2025
3a8fe74a1a06e6587d1ea9cc9ad88657.jpg
.
by dr. Dita Arccinirmala | 04 Jun 2025
ae85f3359d80ca1f60c117821e4f4ad8.jpg
COVID-19 Cases Increased in Several Countries, Is COVID-19 Booster Vaccine Required?
by dr. Dita Arccinirmala | 26 May 2025
405b22b90e7d89d240783e94f21f8b64.jpg
Tripledemic Alert, 3 Concurrent Respiratory Infections
by dr. Dita Arccinirmala | 20 May 2025
9c993147ea20f6e23755dd277c12affd.jpg
Virus that causes COVID-19 variant JN.1 detected in Indonesia, Stay Alert!
by dr. Vivian Keung | 21 Dec 2023
e2171b615c3e4683d2b341b681a4a3fb.jpg
Tocilizumab Effectively Reduces Mortality of Hospitalized COVID-19 Patients; It's a Meta-Analysis Study
by dr. Nugroho Nitiyoso, MBA | 02 Aug 2022
0f73f6fb6c2da93eb54a667caf183c1e.jpg
Baricitinib Beneficial in Reducing Mortality of Hospitalized COVID-19 Patients
by dr. Nugroho Nitiyoso, MBA | 29 Jun 2022
6f35c6ab0fbc1113579bb9bceb8bd1a5.jpg
New Omicron BA.4 and BA.5 Subvariants Detected in Indonesia, Here's What You Need to Know
by dr. Dita Arccinirmala | 14 Jun 2022
150e560335e8cb9fda4e4183841ef20e.jpg
COVID-19 Variant XE, First Discovered in the UK, Here's What You Need to Know
by dr. Dita Arccinirmala | 07 Apr 2022
da78bf45e25b9767379ce99226aebb3b.jpg
Chemotherapy for breast cancer patients during pandemic
by Dr. Hastarita | 23 Mar 2022